Navigation Links
Evolution and the workaround

Living things are resourceful, which is a comforting thought unless the living thing in question is a pathogen or a cancer cell. Noxious cells excel at developing drug resistance, outwitting immune systems, and evading cellular controls. They even show an unhealthy talent for surviving internal perturbations such as mutations that affect the function of vital genes, and they do this by evolving new mechanisms to perform old tasks. Somehow the bad guys find a workaround.

That observation led Norman Pavelka, Giulia Rancati, and Rong Li, researchers at the Stowers Institute for Medical Research in Kansas City, MO, to step back and consider the basic process by which cells adapt to the loss of seemingly irreplaceable genes. The researchers reasoned that understanding how cells adapt to internal perturbations could offer insight into how pathogens and cancer cells mutate to evade the body’s defenses and resist treatment with drugs.

The Stowers researchers used the benign budding yeast Saccharomyces cerevisiae as their model organism and deleted a key cell division gene called MYO1. Surely, eliminating this important gene would shut down cell division. This seemed to be the case in the beginning, and yet as the MYO1 defective cells were cultured and subjected to consecutive rounds of selection for best growers, the yeast came up with new strategies to carry out division. When the researchers analyzed the genetic content of these evolved strains, they found that those who were best at cell division had accumulated multiple copies of many of their chromosomes.

Intriguingly, cancer cells also accumulate extra chromosomes as they become more aggressive. The theory is that these extra chromosomes provide “backup?copies of important genes, allowing the original copies to mutate in ways that help the cells survive stresses (such as drugs) that are meant to kill them.

The observation that both yeast and cancer cells evolve chr omosome duplications to work around lethal stresses suggests that drugs aimed at defeating this process might be particularly effective against pathogens and cancers adept at rapid drug resistance, the researchers say.

To stay alive, you have to be both sturdy and flexible. The Stowers researchers look to these evolved yeast strains for future explanations of how the duplication of genetic information contributes to the robustness and adaptability of all living things.


'"/>

Source:American Society for Cell Biology


Related biology news :

1. To Stop Evolution: New Way Of Fighting Antibiotic Resistance Demonstrated By Scripps Scientists
2. Evolution of taste receptor may have shaped human sensitivity to toxic compounds
3. Evolution of life on Earth may hold key to finding life in outer space
4. Evolutionary conservation of a mechanism of longevity from worms to mammals
5. Evolutionary biology research techniques predict cancer
6. Evolutionary shifts in olfactory sensitivities in fruit flies
7. Evolution follows few of the possible paths to antibiotic resistance
8. Evolution mystery: Spider venom and bacteria share same toxin
9. Evolution of irreducible complexity explained
10. Evolutionary scrap-heap challenge: Antifreeze fish make sense out of junk DNA
11. Evolutionary forces explain why women live longer than men
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/2/2016)... Checkpoint Inhibitors for Cancer – Explore ... you interested in the future of cancer drugs? ... Visiongain,s report gives those predictions to 2026 at ... Avoid falling behind in data or losing ... those emerging cancer therapies can achieve. There you ...
(Date:2/2/2016)...   Parabon NanoLabs (Parabon) announced today ... Office and the Defense Forensics and Biometrics Agency ... company,s Snapshot Kinship Inference software for ... defense-related DNA forensics.  Although Snapshot is best known ... ancestry from DNA evidence), it also has the ...
(Date:2/1/2016)... 1, 2016 Rising sales of ... global touchfree intuitive gesture control market size ... sales of consumer electronics coupled with new technological advancements ... size through 2020   --> ... new technological advancements to drive global touchfree intuitive gesture ...
Breaking Biology News(10 mins):
(Date:2/9/2016)... ... February 09, 2016 , ... PharmApprove ... Policy for the National Organization for Rare Disorders (NORD). Dorman will lead PharmApprove ... voices are heard throughout the drug regulatory review process. , “Adding Diane Dorman ...
(Date:2/9/2016)... BOSTON , Feb. 9, 2016 ... a data-driven, biological research approach, has announced the ... Financial Officer and Chief Operating Officer. Haddock brings ... corporate finance, including 12 years in senior financial ... global experience in business organizational management. ...
(Date:2/8/2016)... -- --> --> ... company developing next generation cancer therapeutics that are ... chairman emeritus of Tata Sons Limited, Mr Ratan ... part of the first close of Invictus,s Series ... and Aarin Capital. http://photos.prnewswire.com/prnh/20150923/766442 ) , ...
(Date:2/8/2016)... ... February 08, 2016 , ... Bulk ... loose, bulk foods at various stages of the production process. Despite frequently inspecting ... large bulk products post packaging such as sacks of dry powders. , Mettler-Toledo ...
Breaking Biology Technology: